Improving Patient Medication Adherence with AI

Medication non-adherence is one of the most expensive and most preventable problems in healthcare. The statistics are staggering: approximately 50 percent of patients with chronic conditions do not take their medications as prescribed. This non-adherence is responsible for an estimated 125,000 deaths per year in the United States and costs the healthcare system $300 billion annually in avoidable hospitalizations, emergency department visits, and disease progression.

For community pharmacists, this represents both a clinical challenge and an opportunity. Pharmacies are the most accessible healthcare touchpoint — patients visit their pharmacy far more frequently than they visit their physician. This positions pharmacists uniquely to identify non-adherent patients and intervene before outcomes deteriorate.

The challenge has always been capacity. A pharmacist filling 250 prescriptions per day does not have time to individually monitor each patient's refill patterns, identify gaps, and conduct targeted outreach. But AI can.

Why Patients Do Not Take Their Medications

Before addressing solutions, it is important to understand the root causes of non-adherence. Research identifies five primary categories:

• Cost: Patients cannot afford their medications, especially after insurance changes or during coverage gaps. They may skip doses, split pills, or abandon prescriptions entirely.
• Side effects: Patients experience side effects and stop taking the medication without consulting their pharmacist or prescriber. Common examples include statins (muscle pain), ACE inhibitors (cough), and metformin (GI upset).
• Complexity: Patients on multiple medications struggle with complex dosing schedules, especially when some medications are taken once daily, others twice, and some with food while others on an empty stomach.
• Misunderstanding: Patients do not understand why the medication is important, how long they need to take it, or what happens if they stop. This is especially common with asymptomatic conditions like hypertension and hyperlipidemia.
• Forgetfulness: Life gets in the way. Patients forget doses, lose track of refills, and let prescriptions lapse during busy periods or transitions (moving, changing jobs, traveling).

How AI Identifies Non-Adherent Patients

The first step in improving adherence is identifying which patients need help. AI-powered systems monitor refill patterns across all of a patient's chronic medications and calculate adherence metrics in real time.

Proportion of Days Covered (PDC)

PDC is the gold standard measure of medication adherence. It calculates the percentage of days in a measurement period during which the patient has medication on hand. A PDC of 80 percent or higher is generally considered adherent. AI systems calculate PDC automatically for every patient on chronic medications and flag patients whose PDC drops below threshold.

Pattern Recognition

Beyond simple PDC calculations, AI identifies patterns that predict future non-adherence. A patient who consistently refills 3 to 5 days late is at higher risk of eventually abandoning the medication than a patient who refills on time. A patient who was adherent for 6 months and then missed a refill may be experiencing a new side effect or a change in insurance coverage. These patterns trigger different intervention strategies.

The difference between AI-powered adherence monitoring and traditional methods is timing. By the time a pharmacy notices a patient has not refilled in 60 days using manual methods, the patient has been without medication for two months. AI detects the gap within days and enables intervention while the patient is still engaged with their therapy.

AI-Powered Interventions

Proactive Refill Reminders

The simplest and most effective intervention is a timely reminder. AI systems calculate when each patient's medication supply will run out and send reminders via the patient's preferred channel — text message, phone call, or email — 3 to 5 days before they are due for a refill. The reminder is personalized, referencing the specific medication and making it easy to request the refill with a single reply.

Targeted Pharmacist Outreach

When a patient's adherence pattern suggests a deeper issue — a new non-fill, a sudden drop in PDC, or a pattern of late refills — the system generates a pharmacist outreach task with context. The pharmacist sees the patient's medication history, adherence trend, and suggested talking points before making the call. This targeted approach means pharmacist time is spent on patients who need clinical intervention, not on routine reminders.

Medication Synchronization

For patients on multiple chronic medications, AI systems can identify candidates for medication synchronization (med sync) programs. Med sync aligns all of a patient's prescriptions to a single refill date each month, reducing the number of pharmacy visits and simplifying the patient's routine. The AI calculates the optimal sync date, adjusts quantities for the initial sync fill, and manages the ongoing schedule.

Cost Optimization

When cost is the barrier to adherence, AI can identify alternatives. This might include therapeutic alternatives with lower copays, manufacturer discount programs, patient assistance programs for which the patient qualifies, or 90-day supply options that reduce per-unit cost. The system presents these options to the pharmacist with the clinical and financial context needed to make a recommendation.

Measuring Impact

Adherence improvement programs need measurable outcomes to justify the investment. Key metrics to track include:

1. PDC improvement: Average PDC across your chronic medication patients before and after implementation
2. Refill capture rate: The percentage of expected refills that are actually filled at your pharmacy
3. New-to-therapy abandonment: The percentage of new prescriptions that are never picked up (industry average is 20 to 30 percent)
4. Star ratings impact: For pharmacies participating in Medicare Part D, adherence measures directly affect star ratings, which influence plan assignment and reimbursement
5. Revenue from recovered refills: Each recovered refill represents $30 to $50 in prescription revenue plus the downstream refills that come from keeping the patient engaged

The Business Case

Adherence improvement is one of those rare opportunities where doing the right thing clinically is also the right thing financially. A pharmacy that fills 200 prescriptions per day and recovers just 5 percent more refills through adherence outreach generates $100,000 to $150,000 in additional annual revenue. For Medicare Part D pharmacies, improved star ratings can mean the difference between preferred and non-preferred plan status — a distinction worth hundreds of thousands of dollars in patient volume.

More importantly, patients who take their medications as prescribed have better outcomes: fewer hospitalizations, fewer ER visits, better disease control, and higher quality of life. This is the clinical mission that drew most pharmacists to the profession in the first place. AI simply makes it possible to deliver on that mission at scale.